| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |